Pages that link to "Q36277783"

The following pages link to Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors (Q36277783):

Displaying 29 items.

• Highlights on the development of A(2A) adenosine receptor agonists and antagonists (Q28279556) (← links)
• Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists. (Q30793386) (← links)
• A3-adenosine receptors: design of selective ligands and therapeutic prospects (Q34204046) (← links)
• The adenosine A3 receptor and its ligands (Q34483322) (← links)
• Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates. (Q34676680) (← links)
• N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors (Q35124859) (← links)
• Adenosine receptor agonists: from basic medicinal chemistry to clinical development (Q35602688) (← links)
• Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy (Q35844532) (← links)
• EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine (Q35849977) (← links)
• Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. (Q36008898) (← links)
• Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering (Q36146803) (← links)
• Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors (Q36243301) (← links)
• Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. (Q36316924) (← links)
• Novel approaches for targeting the adenosine A2A receptor (Q38259766) (← links)
• Determination and validation of LJ-2698, a potent human A3 adenosine receptor antagonist, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic study (Q38649750) (← links)
• Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist (Q38756711) (← links)
• Deoxy Derivatives of L-like 5'-Noraristeromycin (Q39328661) (← links)
• A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy (Q39418010) (← links)
• Adenosine receptors: new opportunities for future drugs. (Q40849413) (← links)
• The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles (Q40984516) (← links)
• Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors (Q41014294) (← links)
• Adenosine A3 receptor and brain. A culprit, a hero, or merely yet another receptor? (Q41643080) (← links)
• Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor. (Q42507509) (← links)
• Synthesis of carbocyclic 2-substituted adenine nucleoside and related analogs (Q46371721) (← links)
• Adenosine A3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons (Q57405391) (← links)
• Recent developments in the field of A3 adenosine receptor antagonists (Q59171613) (← links)
• 2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes (Q63916754) (← links)
• The discovery and synthesis of highly potent, A2a receptor agonists (Q73542469) (← links)
• The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold (Q90356090) (← links)